SBIOvsSPMD
ALPS Medical Breakthroughs ETF against SPDR Portfolio S&P 400 Mid Cap ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| SBIO | SPMD | |
|---|---|---|
| Expense ratio | 0.50% | 0.030% |
| Assets | $114M | $18.4B |
| Net flow, 1 month | — | +$319M |
| Net flow, 1 year | — | +$2.4B |
| Return, YTD | +5.0% | +10.3% |
| Return, 1 year | — | — |
| Avg daily volume | 37K | 2.2M |
| Holdings | 95 | 401 |
| Listed | Dec 30, 2014 | Nov 8, 2005 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS